Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Scott Caroen

Showing results (31-40 of 53) with videos related to

Pageof 6
Sort By:
Frontiers in Oncology|February 13, 2015
The war on cancer: a military perspectiveBryan Oronsky, Corey A Carter, Vernon Mackie, et al.
Translational Oncology|April 27, 2018
A Review of Clinical Radioprotection and Chemoprotection for Oral MucositisBryan Oronsky, Sharad Goyal, Michelle M Kim, et al.
Clinical Colorectal Cancer|December 18, 2022
ROCKET: Phase II Randomized, Active-controlled, Multicenter Trial to Assess the Safety and Efficacy of RRx-001 + Irinotecan vs. Single-agent Regorafenib in Third/Fourth Line Colorectal CancerTony R Reid, Nacer Abrouk, Scott Caroen, et al.
Expert Review of Hematology|April 28, 2017
The macrophage stimulating anti-cancer agent, RRx-001, protects against ischemia-reperfusion injuryPedro Cabrales, Scott Caroen, Arnold Oronsky, et al.
Oncoimmunology|September 20, 2018
A practical guide to the handling and administration of personalized transcriptionally attenuated oncolytic adenoviruses (PTAVs)Christopher Larson, Bryan Oronsky, Gina Varner, et al.
Clinical and Translational Science|June 29, 2023
Data Management 101 for drug developers: A peek behind the curtainBryan Oronsky, Erica Burbano, Meaghan Stirn, et al.
Drugs|March 15, 2023
A Review of RRx-001: A Late-Stage Multi-Indication Inhibitor of NLRP3 Activation and Chronic InflammationNanthini Jayabalan, Bryan Oronsky, Pedro Cabrales, et al.
International Medical Case Reports Journal|December 22, 2022
Clinical Course of Two Patients with COVID-19 Respiratory Failure After Administration of the Anticancer Small Molecule, RRx-001Terese Catherine Hammond, Raymond C Lee, Bryan Oronsky, et al.
Neoplasia (New York, N.Y.)|October 18, 2015
Confirmatory Trials in the Evaluation of Anticancer Medicinal Products in Man--PFS2: A Measure of Therapeutic Action-At-A-DistanceBryan Oronsky, Corey A Carter, Tony R Reid, et al.
Case Reports in Oncology|May 18, 2017
A Case of Paraneoplastic Cushing Syndrome Presenting as Hyperglycemic Hyperosmolar Nonketotic SyndromeChristina E Brzezniak, Nicole Vietor, Patricia E Hogan, et al.
Pageof 6

Showing results (31-40 of 53) with videos related to

Sort By:
Pageof 6
Frontiers in Oncology|February 13, 2015
The war on cancer: a military perspectiveBryan Oronsky, Corey A Carter, Vernon Mackie, et al.
Translational Oncology|April 27, 2018
A Review of Clinical Radioprotection and Chemoprotection for Oral MucositisBryan Oronsky, Sharad Goyal, Michelle M Kim, et al.
Clinical Colorectal Cancer|December 18, 2022
ROCKET: Phase II Randomized, Active-controlled, Multicenter Trial to Assess the Safety and Efficacy of RRx-001 + Irinotecan vs. Single-agent Regorafenib in Third/Fourth Line Colorectal CancerTony R Reid, Nacer Abrouk, Scott Caroen, et al.
Expert Review of Hematology|April 28, 2017
The macrophage stimulating anti-cancer agent, RRx-001, protects against ischemia-reperfusion injuryPedro Cabrales, Scott Caroen, Arnold Oronsky, et al.
Oncoimmunology|September 20, 2018
A practical guide to the handling and administration of personalized transcriptionally attenuated oncolytic adenoviruses (PTAVs)Christopher Larson, Bryan Oronsky, Gina Varner, et al.
Clinical and Translational Science|June 29, 2023
Data Management 101 for drug developers: A peek behind the curtainBryan Oronsky, Erica Burbano, Meaghan Stirn, et al.
Drugs|March 15, 2023
A Review of RRx-001: A Late-Stage Multi-Indication Inhibitor of NLRP3 Activation and Chronic InflammationNanthini Jayabalan, Bryan Oronsky, Pedro Cabrales, et al.
International Medical Case Reports Journal|December 22, 2022
Clinical Course of Two Patients with COVID-19 Respiratory Failure After Administration of the Anticancer Small Molecule, RRx-001Terese Catherine Hammond, Raymond C Lee, Bryan Oronsky, et al.
Neoplasia (New York, N.Y.)|October 18, 2015
Confirmatory Trials in the Evaluation of Anticancer Medicinal Products in Man--PFS2: A Measure of Therapeutic Action-At-A-DistanceBryan Oronsky, Corey A Carter, Tony R Reid, et al.
Case Reports in Oncology|May 18, 2017
A Case of Paraneoplastic Cushing Syndrome Presenting as Hyperglycemic Hyperosmolar Nonketotic SyndromeChristina E Brzezniak, Nicole Vietor, Patricia E Hogan, et al.
Pageof 6